Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.6000
+0.0400
+(1.12%)
As of 12:12:07 PM GMT+1. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
268,517
287,026
168,070
92,290
Total Liabilities Net Minority Interest
13,150
10,083
7,767
23,698
Total Equity Gross Minority Interest
255,367
276,943
160,303
68,592
Total Capitalization
255,367
276,943
160,303
68,592
Preferred Stock Equity
--
--
--
186,033
Common Stock Equity
255,367
276,943
160,303
-117,441
Capital Lease Obligations
603
1,205
--
--
Net Tangible Assets
255,367
276,943
160,303
68,592
Working Capital
255,488
276,717
160,110
68,048
Invested Capital
255,367
276,943
160,303
-104,561
Tangible Book Value
255,367
276,943
160,303
-117,441
Total Debt
603
1,205
--
12,880
Share Issued
64,576.7190
53,723.1710
25,269.2710
22,721.7200
Ordinary Shares Number
64,576.7190
53,723.1710
25,269.2710
22,721.7200
12/31/2020 - 8/17/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NICXF Nicox S.A.
0.2400
0.00%
ANL Adlai Nortye Ltd.
2.2203
+0.92%
TRDA Entrada Therapeutics, Inc.
12.02
-0.83%
CGEM Cullinan Therapeutics, Inc.
8.45
-1.29%
IMCR Immunocore Holdings plc
30.77
+5.34%
MNPR Monopar Therapeutics Inc.
31.29
+0.58%
AGIO Agios Pharmaceuticals, Inc.
34.44
-2.13%
PTGX Protagonist Therapeutics, Inc.
36.15
+3.02%
RNA Avidity Biosciences, Inc.
29.65
+1.68%
ADAP Adaptimmune Therapeutics plc
0.5870
+2.51%